Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,300
Closed -$558K 228
2025
Q4
$558K Buy
5,300
+2,600
+96% +$244K 0.35% 59
2025
Q3
$227K Buy
+2,700
New +$222K 0.12% 111
2025
Q2
Sell
-3,200
Closed -$287K 148
2025
Q1
$287K Buy
3,200
+300
+10% +$28K 0.08% 152
2024
Q4
$288K Sell
2,900
-2,600
-47% -$268K 0.14% 126
2024
Q3
$625K Buy
+5,500
New +$653K 0.21% 70

Other funds holding MRK

XY Capital's MRK Position: Q2 2025 in Review

XY Capital sold out of Merck (MRK) in Q2 2025, closing a stake of 2,223 shares — an estimated $200K sold.

XY Capital first reported a position in MRK in Q3 2024 and held it in 3 quarters. The position peaked at $211K in Q3 2024. 3,328 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • XY Capital reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
  • XY Capital sold 2,223 Merck shares in Q2 2025, an estimated $200K.
  • XY Capital first reported a position in Merck in Q3 2024 and held it in 3 quarters.
  • XY Capital's Merck position peaked at $211K in Q3 2024.
  • 3,328 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on XY Capital's 13F filing for Q2 2025, filed 14 Aug 2025.